Best Agrolife's Fiscal Performance Shines Amidst Sector Challenges

February 06, 2024 11:32 PM IST | By NewsVoir
 Best Agrolife's Fiscal Performance Shines Amidst Sector Challenges
Image source: Kalkine Media

Best Agrolife Ltd. revealed its fiscal performance for the nine months ending December 31, 2023, highlighting a 17% year-on-year revenue growth, totalling Rs. 1738 Cr., despite industry challenges in Q3 FY24. In in 9M FY23 it stood at Rs. 1,492 cr.

This growth has been possible through Best Agrolife's consistent focus on research and development and its customer-centric approach. The companys emphasis on strategic initiatives underscores its commitment to innovation in the sector. Further, despite market challenges in Q3 FY24, the company remains optimistic about the prospects for the upcoming quarter (Q4 FY24) and aim to surpass our annual business targets, with a projected topline exceeding Rs. 2000 Cr. and a healthy EBITDA.

Best Agrolife plans to introduce four patented products and two novel formulations during the Kharif season, reflecting its commitment to innovation. It has also emerged as the first Indian agrochemical firm to secure registration for the indigenous manufacturing of a novel fungicide and insecticide synergistic combination. This formulation is tailored to safeguard crops from damping off disease and various insects, reflecting company's proactive approach to agricultural challenges.

Aiming at global expansion, Best Agrolife recently established a holding company in Mauritius in January 2024. This move is expected to strengthen its presence in the international market, facilitating its entry into the export business.

With its focus on innovation, strategic expansion, and market resilience, Best Agrolife Ltd continues to establish itself as a critical player in the agrochemical industry, poised for sustained growth.

Approvals and Registration received

Further, Seedlings India Pvt. Ltd., a wholly-owned subsidiary of Best Agro Life, has secured approval from the Central Insecticides Board & Registration Committee (CIB&RC) to manufacture a groundbreaking agrochemical domestically. This innovative product, incorporating Trifloxystrobin, Thiamethoxam, and Thiophanate Methyl, is poised to transform Indian agriculture by effectively managing harmful diseases and pests, thereby boosting crop yields. With the patent secured for this innovation, the company is gearing up for a nationwide launch in April 2024, branding it as Warden Extra. The company has also acquired a patent for an innovative synergistic herbicidal composition, which will be introduced nationwide under the brand name Shot Down.

Consolidated Financial Results-Q3 & 9M FY24

Particulars (Rs. Cr.)

Q3 FY24

Q2 FY24

QoQ

Q3 FY23

YoY

9M FY24

9M FY23

9M

YoY

Revenue from operations

315

811

-61%

328

-4%

1,738

1,492

17%

EBITDA

19

144

-87%

58

-68%

293

307

-5%

EBITDA Margin

6%

18%

18%

17%

21%

PAT

(7)

95

-107%

31

-122%

179

201

-11%

EBITDA Margin

-2%

12%

9%

10%

13%


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.